<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03782233</url>
  </required_header>
  <id_info>
    <org_study_id>He Huang</org_study_id>
    <nct_id>NCT03782233</nct_id>
  </id_info>
  <brief_title>Study on the Level of Neuromuscular Blockade</brief_title>
  <official_title>Effect to Gastrointestinal Barrier Function During Laparoscopic Gastrectomy With Deep vs Moderate Neuromuscular Blockade.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital with Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wu Jieping Medical Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The First Affiliated Hospital with Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      On the basis of moderate pneumoperitoneum pressure(10 mmHg), this study evaluates the effect
      of different level of neuromuscular blockade to gastrointestinal barrier function during
      laparoscopic gastrectomy. 60 patients are randomized to 2 arms ,The patients in deep
      NMB（PTC=1-2）will receive high dose rocuronium ;While the patients in moderate
      NMB（TOF=1-2）will receive moderate dose rocuronium.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Different level of neuromuscular blockade can affect the demand of pneumoperitoneum
      pressure,while high level of pneumoperitoneum pressure may cause some damage to
      gastrointestinal barrier which is important to the recovery of the patient. In this study,we
      will evaluate the effect of different level of neuromuscular blockade to the barrier by DAO
      and D-lactic in plasma, the microstructural changes of intestinal tract will be observed
      under scanning electron microscope and the recovery of intestinal function will be recorded.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">January 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of D-lactic</measure>
    <time_frame>1 day before operation,1 day after operation</time_frame>
    <description>The level of D-lactic can indicate the damage to the gastrointestinal barrier .</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Microstructure of the jejunum</measure>
    <time_frame>During operation</time_frame>
    <description>The integrated microstructure of jejunum is the primary of its function，so microstructure of the jejunum will be observed under the SEM and light microscope.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of diamine oxidase（DAO）</measure>
    <time_frame>1 day before operation,1 day after operation</time_frame>
    <description>The level of DAO can indicate the damage to the gastrointestinal barrier .</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative exhaust time</measure>
    <time_frame>immediately after operation</time_frame>
    <description>It's a regular measurement to evaluate the function of gastrointestinal tract .</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Neuromuscular Blockade</condition>
  <arm_group>
    <arm_group_label>deep neuromuscular blockade</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients undergoing elective laparoscopic surgery for gastrectomy were randomized to receive deep neuromuscular blockade (post-tetanic count 1-2) using high dose rocuronium.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>moderate neuromuscular blockade</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients undergoing elective laparoscopic surgery for gastrectomy were randomized to receive moderate neuromuscular blockade (train-of-four 1-2) using moderate dose rocuronium.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium Bromide, 50 Mg/5 mL Intravenous Solution</intervention_name>
    <description>60 patients receiving laparoscopic gastrectomy surgery are randomized to two arms(30 patients per arm). The patients in deep NMB（PTC=1-2）receive high dose rocuronium ;the patients in moderate NMB(TOF=1-2) receive moderate dose rocuronium.</description>
    <arm_group_label>deep neuromuscular blockade</arm_group_label>
    <arm_group_label>moderate neuromuscular blockade</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age:40-80，BMI&lt;30kg/m2；

          2. ASA grade:Ⅰ-Ⅲ；

          3. Planning to receive laparoscopic gastrectomy；

          4. General anesthesia and non-depolarizing muscle relaxant rocuronium bromide were given
             for endotracheal intubation and muscle relaxant maintenance.

          5. Willing to sign informed consent.

        Exclusion Criteria:

          1. Preoperative history of diseases of digestive system such as inflammatory bowel
             disease and intestinal flora disorder;

          2. Suffering severe heart, lung, liver, kidney or brain diseases;

          3. serious infections , antibiotics should be used;

          4. Have received abdominal surgery;

          5. Combined with gravis myasthenia, serious electrolyte disorders or neuromuscular
             diseases.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The First Affiliated Hospital with Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>December 11, 2018</study_first_submitted>
  <study_first_submitted_qc>December 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 20, 2018</study_first_posted>
  <last_update_submitted>December 19, 2018</last_update_submitted>
  <last_update_submitted_qc>December 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neuromuscular Blockade</keyword>
  <keyword>Gastrointestinal Barrier Function</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bromides</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>July 26, 2020</submitted>
    <submission_canceled>July 26, 2020</submission_canceled>
    <submitted>July 27, 2020</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

